Interview with André Choulika, President, France Biotech
France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your opinion, what has caused this?…
Address: Place de la Bourse, Lyon 69289,France
Tel: 33 (0) 4 72 40 57 50
Web: http://www.aderly.com/developpement-economique/agence-developpement-economique,p,0,FR.jsp?null=
A specialist in company set-up and development projects, Aderly serves as a facilitator. It provides your firm with a single contact, sharing its experience and in-depth knowledge of the local area with you, and working in a network with a host of other organizations involved in company set-up and relocation activities. Aderly strives to build long-term relationships and provides continuous “customer service” once your business has been set up in Lyon.
Our services include:
Feasibility studies and specifications
Finding facilities that meet your needs
Regulatory and fiscal advice
Administrative procedures
Fundraising
Putting you in contact with local authorities
Recruitment
Welcoming your employees and helping them get settled in: housing searches, children’s schooling, job searches for spouses and more.
France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your opinion, what has caused this?…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within the pharmacy. Could you…
The US chooses to price its innovative drugs based on a market approach which is very different from the French system. Could you explain how the French model rewards innovative…
The creation of AFSSAPS in 1999 was a milestone for the industry as it became the organism which gives authorization to enter a drug into the market. Can you explain…
What was the idea behind the creation of the « Etats Generaux de l’industrie » (General States of Industries)? What can we expect from them? The main idea is that…
See our Cookie Privacy Policy Here
